AHA: Rising Outdoor Temperatures Tied to Higher Risk for Atrial Fibrillation
By Lori Solomon HealthDay Reporter
MONDAY, Nov. 18, 2024 -- There is a dose-response relationship between rising outdoor temperatures and increased atrial fibrillation (AF) events, according to a study presented at the American Heart Association Scientific Sessions 2024, held from Nov. 16 to 18 in Chicago.
Barrak Alahmad, M.D., Ph.D., M.P.H., from Harvard University in Boston, and colleagues examined the role of emerging environmental risk factors, like extreme heat driven by climate change. The Medtronic Product Surveillance Registry was used to identify 2,313 patients who received a cardioverter-defibrillator or cardiac resynchronization therapy defibrillator device implant (2016 to 2023) and had an atrial arrhythmic event.
The researchers found significantly fewer AF episodes in the early morning hours (12 to 7 a.m.) compared with normal working hours (8 a.m. to 5 p.m.). There were also significantly fewer AF episodes occurring on Saturday and Sunday versus weekdays. Compared with locally optimal temperatures across the United States (those associated with least odds; between 5 to 8 degrees Celsius), the odds of AF events increased when outdoor temperatures were 39, 40, and 41 degrees Celsius. The models did not improve with lagging temperature exposure. For AF episodes >30 minutes, results were similar.
"This study highlights the urgent need to consider emerging environmental factors, such as climate change-induced heat, in managing and preventing AF," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-19 06:00
Read more
- Women With Severe Maternal Morbidity Less Likely to Have Subsequent Birth
- Trump Says RFK Jr. Free to Revisit Discredited Autism/Vaccine Link
- Trump Picks Vaccine Mandate Critic Dr. Jay Bhattacharya to Head National Institutes of Health
- Long-Term Exposure to Air Pollution Tied to More Hospital Admissions
- Moderate-to-Vigorous Exercise Lowers Preterm Birth Risk With Gestational Diabetes
- Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions